| Literature DB >> 33457433 |
Christopher Sheu1, Richard D Ferkel2.
Abstract
BACKGROUND: Use of marrow-stimulating techniques to treat osteochondral lesions of the talus (OLTs) in National Basketball Association (NBA) players is controversial. HYPOTHESIS: NBA players will be able to return to preinjury playing status after treatment of OLTs by arthroscopic debridement alone without marrow-stimulating techniques. STUDYEntities:
Keywords: NBA players; National Basketball Association; OCD; osteochondral lesions of the talus; return to sport
Year: 2021 PMID: 33457433 PMCID: PMC7802091 DOI: 10.1177/2325967120970205
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
NBA Player and Performance Variables
| Variable (Abbreviation) |
|---|
| Seasons played (SP) |
| Games played (GP) |
| Games started (GS) |
| Minutes per game (MIN) |
| Points per game (PPG) |
| Field goal percentage (FG%) |
| Three-point percentage (3P%) |
| Rebounds (REB) |
| Assists (AST) |
| Steals (STL) |
| Blocks (BLK) |
| Turnovers (TO) |
| Personal fouls (PF) |
| Double doubles (DBLDBL) |
| Triple doubles (TRIDBL) |
| Assists per turnovers (AST/TO) |
| Steals per turnovers (STL/TO) |
| NBA rating (RAT) |
| Scoring efficiency (SCEFF) |
| Shooting efficiency (SHEFF) |
NBA, National Basketball Association.
Figure 1.Mean field goal percentage change from rookie season versus time from surgery. YR, year.
Player Characteristics
| Player | Age at Surgery, y | Years in NBA After Surgery | Position | Round Drafted | Location of Lesion (Dome) | Size of Lesion, mm |
|---|---|---|---|---|---|---|
| 1 | 24 | 4 | PG | First | Middle lateral | 5 × 3 |
| 2 | 26 | 1 | SG | Second | Anterolateral | 5 × 3 |
| 3 | 23 | 1 | PG | First | Centrolateral | 10 × 10 |
| 4 | 22 | 10 | PG | First | Posteromedial | 12 × 7 |
| 5 | 21 | 2 | SG | Second | Middle lateral | 5 × 8 |
| 6 | 24 | 9 | PF | First | Posterolateral | 5 × 5 |
| 7 | 24 | 1 | PG | First | Posteromedial | 7 × 2 |
| 8 | 28 | 1 | C | Undrafted | Anterolateral | 13 × 4 |
| 9 | 28 | 11 | SG | First | Middle lateral | 10 × 4 |
| 10 | 32 | 2 | PG | First | Posterolateral | 8 × 6 |
C, center; NBA, National Basketball Association; PF, power forward; PG, point guard; SG, shooting guard.
Active in league as of the end of this study.
Variables of Cases and Controls
| Variable | No. | Minimum | Q1 | Median | Mean ± SD | Q3 | Maximum |
|---|---|---|---|---|---|---|---|
| Age, y | |||||||
| Cases | 10 | 21.2 | 23.4 | 24.0 | 25.3 ± 3.2 | 28.0 | 32.0 |
| Controls | 20 | 20.0 | 22.5 | 24.0 | 24.4 ± 2.6 | 26.0 | 29.0 |
| Height, cm | |||||||
| Cases | 10 | 182.9 | 188.0 | 190.5 | 194.3 ± 9.1 | 200.7 | 210.8 |
| Controls | 20 | 182.9 | 190.5 | 191.8 | 194.8 ± 8.6 | 198.1 | 210.8 |
| Weight, kg | |||||||
| Cases | 10 | 79.8 | 86.2 | 90.7 | 93.8 ± 11.8 | 99.2 | 117.9 |
| Controls | 20 | 79.8 | 86.2 | 90.7 | 93.8 ± 11.5 | 95.2 | 117.9 |
| BMI | |||||||
| Cases | 10 | 23.6 | 23.8 | 24.3 | 24.6 ± 1.1 | 25.0 | 27.2 |
| Controls | 20 | 23.6 | 23.8 | 24.3 | 24.6 ± 1.1 | 25.0 | 27.2 |
| Years in league | |||||||
| Cases | 10 | 2.0 | 4.0 | 6.5 | 7.7 ± 5.0 | 11.0 | 18.0 |
| Controls | 20 | 6.0 | 8.0 | 10.0 | 10.8 ± 3.9 | 13.0 | 18.0 |
| Area of lesion, mm2 | |||||||
| Cases | 10 | 14 | 15 | 32.5 | 41.88 ± 33.09 | 63 | 100 |
Cases and controls were matched 1:2 by BMI, height, weight, and position. BMI, body mass index; Q1, 25th percentile; Q3, 75th percentile.
Figure 2.(A) Coronal T2-weighted MRI shows a subtle, small, minimally displaced chondral flap along the posterolateral talar dome (arrow) with minimal fluid tracking beneath the flap. (B) Sagittal T2-weighted MRI depicts the same chondral flap, which appears to remain attached anteriorly (arrow). (C) Coronal CT arthrogram shows a small, full-thickness chondral defect evident along the lateral talar dome (arrow) without significant displacement. (D) Sagittal CT arthrogram again shows a small, full-thickness chondral defect (arrow) with no significant osseous fracture fragment. CT, computed tomography; MRI, magnetic resonance imaging.
Figure 3.(A) Centrolateral talar dome lesion noted from the anteromedial portal in a left ankle. (B) A probe is inserted from the anterolateral portal and is used to assess the stability of the cartilage flap. (C) The unstable cartilage flap (10 × 10 mm) is removed with a grasper through the anterolateral portal. (D) The centrolateral talar dome after debridement as visualized from the posterolateral portal. The probe is coming from the anterolateral portal.